JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allen, T. M.
Right arrow Articles by Everest, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allen, T. M.
Right arrow Articles by Everest, J. M.

Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats

TM Allen and JM Everest

The organ distribution and half-life in blood of liposome-entrapped [14C]sucrose was examined in rats for two compositions of liposomes having widely differing drug release properties as determined by an in vitro assay in the presence of serum at 37 degrees C. The liposomes were composed of 1) egg phosphatidylcholine-cholesterol, 2:1 molar ratio and of 2) bovine brain sphingomyelin-phosphatidylcholine, 4:1 molar ratio. The two types of liposome were determined to have half- lives for release of contents in vitro in the presence of serum of 2.6 and 35 hr, respectively. Organ distribution and blood values were followed with time for small unilamellar, multilamellar and reverse- phase evaporation liposomes of both compositions. Free [14C]sucrose was almost totally eliminated from rats within 0.5 hr of injection. Liposome-entrapment increased the circulation time of sucrose in vivo in the following order: small unilamellar greater than reverse-phase evaporation greater than multilamellar liposomes. For all sizes of liposomes, the composition with slower leakage as determined by in vitro assay (sphingomyelin-phosphatidylcholine, 4:1) resulted in significantly longer half-lives in blood and in whole body. Liposomes containing sphingomyelin were taken up by liver to a lesser extent and by spleen to a greater extent than phosphatidylcholine-cholesterol liposomes of all sizes.

Volume 226, Issue 2, pp. 539-544, 08/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Cancer Res.Home page
G. Kong, R. D. Braun, and M. W. Dewhirst
Hyperthermia Enables Tumor-specific Nanoparticle Delivery: Effect of Particle Size
Cancer Res., August 1, 2000; 60(16): 4440 - 4445.
[Abstract] [Full Text]

Home page
 ScienceHome page
C. Hunt, R. Burnette, R. MacGregor, A. Strubbe, D. Lau, N Taylor, and H Kiwada
Synthesis and evaluation of a prototypal artificial red cell
Science, December 6, 1985; 230(4730): 1165 - 1168.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics.